2026 Global: Biopharmaceutical Excipients Market -Competitive Review (2032) report
Description
The 2026 Global: Biopharmaceutical Excipients Market -Competitive Review (2031) report features the global market size and projected growth/decline data for the period 2021 through 2032. The report primarily provides an examination of the business strategies for the ten largest global companies in the market and how their strategies differ.
Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2021 to 2032 using regression analysis in our modeling. and Perry/Hope is the only market research publisher that utilizes both longitudinal (historical) and vertical (from market section to market division to market class) analysis, since we study every manufactured product in the countries we analyze. The report also provides written analysis on the market definition, market segments, and SWOT analysis (market strengths, weaknesses, opportunities, and threats).
The market study aims at estimating the market size and the growth potential of this market. Topics analyzed within the report include a detailed breakdown of the global markets for biopharmaceutical excipients market by geography and historical trend. The scope of the report extends to sizing of the biopharmaceutical excipients market market and global market trends with market data for 2024 as the base year, 2025 and 2026 as the estimate years with projection of CAGR from 2027 to 2032.
The report also features a list of the top ten largest global players in the market. A review of each company includes 1) an estimate of the market share, 2) a listing of the products and/or services in the market, and 3) the features of these products and/or services in the market. The report has a chapter on Comparative Business Strategies for the largest four players. An example of the Comparative Business Strategies analysis would be -- How does Netflix's business strategy to expand its market share in the global online streaming compare to Amazon Prime's business strategy through its video products and services?
The ten market players in this report and a brief synopsis of their participation in the market are:
The biopharmaceutical excipients market features ten major companies driving innovation in stabilizers, polymers, and lipid-based ingredients essential for biologics, vaccines, and advanced formulations. BASF SE, headquartered in Ludwigshafen, Germany, leads with a broad portfolio of pharmaceutical-grade excipients, including polymers, polyethylene glycols, and solubilizers for controlled release and poorly soluble APIs, emphasizing regulatory compliance and bioavailability enhancement. Evonik Industries AG excels in specialty excipients like the EUDRAGIT® line for sustained-release coatings and functional lipids for mRNA nanoparticles, integrating digital modeling for efficient manufacturing. Roquette Frères S.A., based in Lestrem, France, dominates plant-based solutions such as starch derivatives, sugars, and LYCAGEL®, supporting oral, injectable, and nutraceutical applications with sustainable sourcing. Ashland Global Holdings Inc. provides cellulose-based polymers like HPMC and CMC for film coatings, binders, and disintegrants, focusing on oral solid dosage forms and biologics. Croda International Plc innovates in natural lipids, emulsifiers, and surfactants via its Avanti Polar Lipids subsidiary, critical for liposomal delivery and mRNA therapeutics.
Archer Daniels Midland (ADM) supplies plant-derived excipients including starches, sorbitol, dextrose, and citric acid, compliant with global pharmacopeia standards and integral to the supply chain for biopharma feedstocks. Kerry Group Plc offers functional natural excipients from food-grade expertise, prioritizing process innovation and sustainability for consistent pharmaceutical supply. Lubrizol Corporation, in Wickliffe, Ohio, specializes in Carbopol® polymers, polycarbophil, and solubility enhancers for injectables and controlled release, bolstering formulation stability. DuPont (now integrated with IFF) delivers cellulose-based and marine-derived excipients like Avicel for solid oral dosages, enhancing patient-friendly biopharma formulations post-Nutrition & Biosciences merger. International Flavors & Fragrances (IFF), following its DuPont integration, advances multifunctional excipients for complex biologics, holding significant market share through global partnerships and R&D.
These companies collectively command 30-40% of the market, fueled by expansions like Evonik’s 2024 spray-drying plant and GELITA’s 2025 endotoxin-controlled launches, amid rising demand for bio-derived and AI-optimized excipients. North America and Europe lead due to robust R&D ecosystems, with Asia-Pacific emerging via manufacturing hubs. Strategic mergers, sustainability initiatives, and regulatory adherence position them to meet biopharma growth from USD 3.0 billion in 2024 to USD 6.3 billion by 2035. Their focus on high-purity, multifunctional products ensures resilience against stringent FDA/EMA standards and supply chain challenges.
Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2021 to 2032 using regression analysis in our modeling. and Perry/Hope is the only market research publisher that utilizes both longitudinal (historical) and vertical (from market section to market division to market class) analysis, since we study every manufactured product in the countries we analyze. The report also provides written analysis on the market definition, market segments, and SWOT analysis (market strengths, weaknesses, opportunities, and threats).
The market study aims at estimating the market size and the growth potential of this market. Topics analyzed within the report include a detailed breakdown of the global markets for biopharmaceutical excipients market by geography and historical trend. The scope of the report extends to sizing of the biopharmaceutical excipients market market and global market trends with market data for 2024 as the base year, 2025 and 2026 as the estimate years with projection of CAGR from 2027 to 2032.
The report also features a list of the top ten largest global players in the market. A review of each company includes 1) an estimate of the market share, 2) a listing of the products and/or services in the market, and 3) the features of these products and/or services in the market. The report has a chapter on Comparative Business Strategies for the largest four players. An example of the Comparative Business Strategies analysis would be -- How does Netflix's business strategy to expand its market share in the global online streaming compare to Amazon Prime's business strategy through its video products and services?
The ten market players in this report and a brief synopsis of their participation in the market are:
The biopharmaceutical excipients market features ten major companies driving innovation in stabilizers, polymers, and lipid-based ingredients essential for biologics, vaccines, and advanced formulations. BASF SE, headquartered in Ludwigshafen, Germany, leads with a broad portfolio of pharmaceutical-grade excipients, including polymers, polyethylene glycols, and solubilizers for controlled release and poorly soluble APIs, emphasizing regulatory compliance and bioavailability enhancement. Evonik Industries AG excels in specialty excipients like the EUDRAGIT® line for sustained-release coatings and functional lipids for mRNA nanoparticles, integrating digital modeling for efficient manufacturing. Roquette Frères S.A., based in Lestrem, France, dominates plant-based solutions such as starch derivatives, sugars, and LYCAGEL®, supporting oral, injectable, and nutraceutical applications with sustainable sourcing. Ashland Global Holdings Inc. provides cellulose-based polymers like HPMC and CMC for film coatings, binders, and disintegrants, focusing on oral solid dosage forms and biologics. Croda International Plc innovates in natural lipids, emulsifiers, and surfactants via its Avanti Polar Lipids subsidiary, critical for liposomal delivery and mRNA therapeutics.
Archer Daniels Midland (ADM) supplies plant-derived excipients including starches, sorbitol, dextrose, and citric acid, compliant with global pharmacopeia standards and integral to the supply chain for biopharma feedstocks. Kerry Group Plc offers functional natural excipients from food-grade expertise, prioritizing process innovation and sustainability for consistent pharmaceutical supply. Lubrizol Corporation, in Wickliffe, Ohio, specializes in Carbopol® polymers, polycarbophil, and solubility enhancers for injectables and controlled release, bolstering formulation stability. DuPont (now integrated with IFF) delivers cellulose-based and marine-derived excipients like Avicel for solid oral dosages, enhancing patient-friendly biopharma formulations post-Nutrition & Biosciences merger. International Flavors & Fragrances (IFF), following its DuPont integration, advances multifunctional excipients for complex biologics, holding significant market share through global partnerships and R&D.
These companies collectively command 30-40% of the market, fueled by expansions like Evonik’s 2024 spray-drying plant and GELITA’s 2025 endotoxin-controlled launches, amid rising demand for bio-derived and AI-optimized excipients. North America and Europe lead due to robust R&D ecosystems, with Asia-Pacific emerging via manufacturing hubs. Strategic mergers, sustainability initiatives, and regulatory adherence position them to meet biopharma growth from USD 3.0 billion in 2024 to USD 6.3 billion by 2035. Their focus on high-purity, multifunctional products ensures resilience against stringent FDA/EMA standards and supply chain challenges.
Table of Contents
32 Pages
- 1.0 Scope of Report and Methodology
- 2.0 Market SWOT Analysis and Players
- 2.1 Market Definition
- 2.2 Market Segments
- 2.3 Market Strengths
- 2.4 Market Weaknesses
- 2.5 Market Threats
- 2.6 Market Opportunities
- 2.7 Major Players
- 3.0 Competitive Analysis
- 3.1 Market Player 1
- 3.2 Market Player 2
- 3.3 Market Player 3
- 3.4 Market Player 4
- 3.5 Market Player 5
- 3.6 Market Player 6
- 3.7 Market Player 7
- 3.8 Market Player 8
- 3.9 Market Player 9
- 3.10 Market Player 10
- 4.0 Comparative Business Strategies
- 4.1 Comparative Business Strategies of Player 1 and 2
- 4.2 Comparative Business Strategies of Player 1 and 3
- 4.3 Comparative Business Strategies of Player 1 and 4
- 4.4 Comparative Business Strategies of Player 2 and 3
- 4.5 Comparative Business Strategies of Player 2 and 4
- 4.6 Comparative Business Strategies of Player 3 and 4
- 5.0 Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.